title: Lowering immunosuppression is safe and effective to treat altered pattern of CMV infection in renal transplant recipients on valaciclovir prophylaxis.
authors.affiliation: Service de Néphrologie et de Transplantation Rénale, Hôpital Saint Louis, Paris, France.
authors.forename: D
authors.initials: D
authors.lastname: Anglicheau
authors.forename: A
authors.initials: A
authors.lastname: Lautrette
authors.forename: C
authors.initials: C
authors.lastname: Scieux
authors.forename: E
authors.initials: E
authors.lastname: Thervet
authors.forename: F
authors.initials: F
authors.lastname: Martinez
authors.forename: M
authors.initials: M
authors.lastname: Flamant
authors.forename: F
authors.initials: F
authors.lastname: Morinet
authors.forename: C
authors.initials: C
authors.lastname: Legendre
mesh_terms: D000212:Acyclovir / Q000031:analogs & derivatives* / Q000627:therapeutic use*; D000956:Antigens, Viral / Q000097:blood; D000998:Antiviral Agents / Q000627:therapeutic use*; D003586:Cytomegalovirus Infections / Q000188:drug therapy / Q000517:prevention & control*; D004305:Dose-Response Relationship, Drug; D004359:Drug Therapy, Combination; D006801:Humans; D007165:Immunosuppression Therapy / Q000379:methods*; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000627:therapeutic use; D016030:Kidney Transplantation / Q000276:immunology*; D011355:Prodrugs / Q000627:therapeutic use; D000077483:Valacyclovir; D014633:Valine / Q000031:analogs & derivatives* / Q000627:therapeutic use*
chemical_list: D000956:Antigens, Viral; D000998:Antiviral Agents; D007166:Immunosuppressive Agents; D011355:Prodrugs; D014633:Valine; D000077483:Valacyclovir; D000212:Acyclovir